
HHS, DARPA link up with Rutgers, Cost Plus Drugs and others in initiative to rethink US drug production
On the heels of a production-tinged executive order earlier this month, the Trump administration is doubling down on efforts to boost medicine manufacturing in the U.S. In a new public-private partnership spearheaded by the administration, the Department …